Clinical Effectiveness and Cost-Effectiveness of the Use of the Thyroxine/Thyroxine-Binding Globulin Ratio to Detect Congenital Hypothyroidism of Thyroidal and Central Origin in a Neonatal Screening Program
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Context. Since the introduction of screening for congenital hypothyroidism (CH) in 1974, the optimal laboratory strategy has been the subject of debate. Objective. To assess the clinical effectiveness and cost-effectiveness of various types of thyroxine (T4)-based strategies to screen for CH. Design, Setting, and Participants. In the Netherlands, since January 1, 1995, a primary T4 determination with supplemental thyroid-stimulating hormone (TSH) and T4-binding globulin (TBG) measurements has been used. Results were calculated from cumulative findings for 1181079 children screened between January 1, 1995, and December 31, 2000. Main Outcome Measures. Rates of detection of patients with CH of thyroidal origin (CH-T) or CH of central origin (CH-C), false-positive rates, laboratory costs, and costs of initial diagnostic evaluations. Results. All known infants (n = 393) with CH-T and 92% (n = 66) of infants with CH-C were detected on the basis of low T4 levels, TSH elevation, and/or low T4/TBG ratios. If the decision to refer had been based solely on TSH elevation, then 94% of patients with CH-T and none of the patients with CH-C would have been detected. If low T4 levels (≤−3.0 SD) and TSH elevation had been used as the criteria for referral, then the rates of detection would have been 96% for CH-T and 31% for CH-C. The false-positive rates for the 3 approaches were 0.5, 3.3, and 4.7 cases per case detected, respectively. The introduction of the T4/TBG ratio into a program using a primary T4 with supplemental TSH approach generates an extra cost of $11206 per additional case detected. The average costs to detect 1 patient are comparable for the 3 approaches. In addition, our data revealed a substantially greater prevalence of CH-C than reported previously (1 case per 16404 children, compared with earlier estimates of 1 case per 26000 infants to 1 case per 29000 infants). Conclusions. The T4 plus TSH plus TBG approach is a recommendable strategy for neonatal CH screening. It offers outstanding detection of patients with CH-C, in addition to those with CH-T, with acceptable costs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TBG measurement prevents false-positive results due to TBG deficiency (5).”
From Cognitive and Motor Outcome in Patients with Early-Detected Central Congenital Hypothyroidism Compared with Siblings (2021) · cites this paper as [5]
In the citing paper
“Since 1995, the Dutch neonatal screening program has consisted of a 3-step approach, with T4 measurement as the first step in all neonates, TSH measurement in the lowest 20% of T4 concentrations, and thyroxine-binding globulin (TBG) measurement in the lowest 5%.”
From Cognitive and Motor Outcome in Patients with Early-Detected Central Congenital Hypothyroidism Compared with Siblings (2021) · cites this paper as [5]
In the citing paper
“This approach effectively detects primary and central CH.”
From Cognitive and Motor Outcome in Patients with Early-Detected Central Congenital Hypothyroidism Compared with Siblings (2021) · cites this paper as [5]
In the citing paper
“To date, central CH is the only pituitary hormone deficiency accessible for neonatal screening, which can be performed cost-effectively (5).”
From Cognitive and Motor Outcome in Patients with Early-Detected Central Congenital Hypothyroidism Compared with Siblings (2021) · cites this paper as [5]
In the citing paper
“The reported incidence of central CH detected through neonatal screening lies between 1 in 30,000 and 1 in 16,000, depending on the screening strategy (22–26).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Inactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital Hypothyroidism
Moreno, J. C., Bikker, H., Kempers, M. J. E., van Trotsenburg, A. S. P., Baas, F., de Vijlder, J. J. M., Vulsma, T., & Ris-Stalpers, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012752 · Cited by 485
Self-citationScreening for congenital hypothyroidism: Results of screening one million North American infants
Fisher, D. A., Dussault, J. H., Foley, T. P., Klein, A. H., LaFranchi, S., Larsen, P. R., Mitchell, M. L., Murphey, W. H., & Walfish, P. G. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80133-x · Cited by 372
What Do We Gain from the Sixth Stool Guaiac?
Neuhauser, D., & Lewicki, A. M. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507312930504 · Cited by 189
Oxford Handbook of Endocrinology and Diabetes
(2014) · doi:10.1093/med/9780199644438.001.0001 · Cited by 177
Kempers, M. J. E., van Tijn, D. A., van Trotsenburg, A. S. P., de Vijlder, J. J. M., Wiedijk, B. M., & Vulsma, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030665 · Cited by 160
Self-citationSecond International Conference on NeonatalThyroid Screening: Progress report
Fisher, D. A. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80228-5 · Cited by 125
Hanna, C. E., Krainz, P. L., Skeels, M. R., Miyahira, R. S., Sesser, D. E., & LAFRANCHI, S. H. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80276-1 · Cited by 104
The Anecdotal History of Screening for Congenital Hypothyroidism
Dussault, J. H. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4332 · Cited by 92
Léger, J., Larroque, B., Norton, J., & AFDPHE (2001) · Acta Paediatrica · doi:10.1080/080352501317130272 · Cited by 87
Cited by
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
Screening for congenital hypothyroidism: A worldwide view of strategies
Ford, G., & LaFranchi, S. H. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.008 · Cited by 274
Loeber, J. G., Platis, D., Zetterström, R. H., Almashanu, S., Boemer, F., Bonham, J. R., Borde, P., Brincat, I., Cheillan, D., Dekkers, E., et al. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7010015 · Cited by 243
“The Netherlands has also been screening for central hypothyroidism since the 1990s via the primary measurement of total thyroxine, supplemented by thyrotropin and thyroxine-binding globulin for samples, with 20% and 5% lowest total thyroxine levels, respectively [29,30].”
BackgroundSelf-citationLéger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · Hormone Research in Paediatrics · doi:10.1159/000358198 · Cited by 208
DIAGNOSIS OF ENDOCRINE DISEASE: Congenital hypothyroidism: update and perspectives
Peters, C., van Trotsenburg, A. S. P., & Schoenmakers, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0383 · Cited by 162
Wassner, A. J. (2018) · Clinics in Perinatology · doi:10.1016/j.clp.2017.10.004 · Cited by 165
Neonatal Detection of Congenital Hypothyroidism of Central Origin
van Tijn, D. A., de Vijlder, J. J. M., Verbeeten, B., Verkerk, P. H., & Vulsma, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2444 · Cited by 139
Self-citationNewborn screening strategies for congenital hypothyroidism: an update
LaFranchi, S. H. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9062-1 · Cited by 121
“A Dutch screening program using the T4/thyroxinebinding globulin (TBG) ratio to detect central hypothyroidism reported an incidence of 1:16,404, likely closer to the true incidence of congenital TSH deficiency (Lanting et al. 2005).”
BackgroundMethodKempers, M. J. E., Lanting, C. I., van Heijst, A. F. J., van Trotsenburg, A. S. P., Wiedijk, B. M., de Vijlder, J. J. M., & Vulsma, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0058 · Cited by 109
Self-citationCongenital hypothyroidism: insights into pathogenesis and treatment
Cherella, C. E., & Wassner, A. J. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0051-0 · Cited by 106
“Moreover, some have suggested that a carefully designed T4-based screening strategy able to detect these infants may actually be more cost effective than TSH-based screening [33].”
BackgroundThe IGSF1 Deficiency Syndrome: Characteristics of Male and Female Patients
Joustra, S. D., Schoenmakers, N., Persani, L., Campi, I., Bonomi, M., Radetti, G., Beck-Peccoz, P., Zhu, H., Davis, T. M. E., Sun, Y., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2743 · Cited by 103
“J Clin Endocrinol Metab 2008; 93(7): 25392545 21.”
BackgroundAre lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted?
Lain, S., Trumpff, C., Grosse, S. D., Olivieri, A., & Van Vliet, G. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0107 · Cited by 96
“Although the costs associated with collecting repeat samples are not insignificant, (71) particularly when the cost to a family of a clinic visit or the cost of a midwife’s home visit are included, the vast majority of those recalled receive one additional blood test with normal results and no…”
Van Uytfanghe, K., Ehrenkranz, J., Halsall, D., Hoff, K., Loh, T. P., Spencer, C. A., Köhrle, J., & ATA Thyroid Function Tests Writing Group (2023) · Thyroid® · doi:10.1089/thy.2023.0169 · Cited by 100
Pediatric Hypothyroidism: Diagnosis and Treatment
Wassner, A. J. (2017) · Pediatric Drugs · doi:10.1007/s40272-017-0238-0 · Cited by 116
Diagnosis and Management of Central Congenital Hypothyroidism
Lauffer, P., Zwaveling‐Soonawala, N., Naafs, J. C., Boelen, A., & van Trotsenburg, A. S. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.686317 · Cited by 90
“Thereby primary CH is detected, but central CH is missed (11, 16).”
BackgroundNewborn Screening Results in Children with Central Hypothyroidism
Nebesio, T. D., McKenna, M. P., Nabhan, Z. M., & Eugster, E. A. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.12.011 · Cited by 70
Introducing new screens: Why are we all doing different things?
Pollitt, R. J. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0647-2 · Cited by 69
Kempers, M. J. E., van Trotsenburg, A. S. P., van Rijn, R. R., Smets, A. M. J. B., Smit, B. J., de Vijlder, J. J. M., & Vulsma, T. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2042 · Cited by 63
“In The Netherlands, neonates with central congenital hypothyroidism (CH-C) are detected by a T4-based neonatal screening program (1, 2).”
BackgroundSelf-citationFetal and neonatal thyroid function: review and summary of significant new findings
Raymond, J. K., & LAFRANCHI, S. H. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328333b0b2 · Cited by 63
van Tijn, D. A., de Vijlder, J. J. M., & Vulsma, T. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2656 · Cited by 56
Self-citationTrisomy 21 Causes Persistent Congenital Hypothyroidism Presumably of Thyroidal Origin
Trotsenburg, A. S. P. V., Kempers, M. J. E., Endert, E., Tijssen, J. G. P., Vijlder, J. J. M. D., & Vulsma, T. (2006) · Thyroid · doi:10.1089/thy.2006.16.671 · Cited by 53
“Depending on the neonatal CH screening method, the higher than expected percentages of DS neonates with an abnormal screening result can be explained by their left-shifted T 4 or simultaneously right-shifted TSH concentrations frequency distributions (14,31,32).”
Self-citationDonaldson, M., & Jones, J. H. (2012) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.849 · Cited by 60
The Severity of Congenital Hypothyroidism of Central Origin Should Not Be Underestimated
Zwaveling-Soonawala, N., van Trotsenburg, A. S. P., & Verkerk, P. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2871 · Cited by 49
Self-citationUlph, F., Wright, S. J., Dharni, N., Payne, K., Bennett, R., Roberts, S. A., Walshe, K., & Lavender, T. (2017) · Health Technology Assessment · doi:10.3310/hta21550 · Cited by 49
Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision)
Nagasaki, K., Minamitani, K., Anzo, M., Adachi, M., Ishii, T., Onigata, K., Kusuda, S., Harada, S., Horikawa, R., Minagawa, M., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.107 · Cited by 50
Chen, C., Lee, K., Lee, C. T., Lai, W., & Huang, Y. (2012) · Journal of Epidemiology · doi:10.2188/jea.je20120113 · Cited by 45
Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision)
Nagasaki, K., Minamitani, K., Nakamura, A., Kobayashi, H., Numakura, C., Itoh, M., Mushimoto, Y., Fujikura, K., Fukushi, M., & Tajima, T. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0063 · Cited by 50
IGSF1 deficiency syndrome: A newly uncovered endocrinopathy
Joustra, S. D., van Trotsenburg, A. S. P., Sun, Y., Losekoot, M., Bernard, D. J., Biermasz, N. R., Oostdijk, W., & Wit, J. M. (2013) · Rare Diseases · doi:10.4161/rdis.24883 · Cited by 36
“The Dutch screening program, using the T4+TSH+TBG approach, reported an CH-C incidence of 1:16,404.(14) This represented 13.”
Mutations in IRS4 are associated with central hypothyroidism
Heinen, C. A., de Vries, E. M., Alders, M., Bikker, H., Zwaveling-Soonawala, N., van den Akker, E. L. T., Bakker, B., Hoorweg-Nijman, G., Roelfsema, F., Hennekam, R. C., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-105113 · Cited by 38
Naafs, J. C., Verkerk, P. H., Fliers, E., van Trotsenburg, A. S. P., & Zwaveling-Soonawala, N. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0833 · Cited by 35
Self-citationNeonatal screening for primary and central congenital hypothyroidism: is it time to go Dutch?
Boelen, A., Zwaveling‐Soonawala, N., Heijboer, A. C., & van Trotsenburg, A. S. P. (2023) · European Thyroid Journal · doi:10.1530/etj-23-0041 · Cited by 54
Neonatal thyroid screening results are related to gestational maternal thyroid function
Kuppens, S. M., Kooistra, L., Wijnen, H. A. A., Vader, H. L., Hasaart, T. H. M., Oei, S. G., Vulsma, T., & Pop, V. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04083.x · Cited by 36
Self-citationFamilial Central Hypothyroidism Caused by a Novel IGSF1 Gene Mutation
Tenenbaum‐Rakover, Y., Turgeon, M., London, S., Hermanns, P., Pohlenz, J., Bernard, D. J., & Bercovich, D. (2016) · Thyroid · doi:10.1089/thy.2015.0672 · Cited by 34
Roche, E. F., McGowan, A., Koulouri, O., Turgeon, M., Nicholas, A. K., Heffernan, E., El‐Khairi, R., Abid, N., Lyons, G., Halsall, D., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13827 · Cited by 29
Central regulation of the hypothalamo–pituitary–thyroid (HPT) axis
Fliers, E., Boelen, A., & van Trotsenburg, A. S. P. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00009-5 · Cited by 34
Central Hypothyroidism in Children
García, M., Fernández, A., & Moreno, J. C. (2014) · Endocrine Development · doi:10.1159/000363157 · Cited by 28
Rowe, A. D., Stoway, S. D., Åhlman, H., Arora, V., Caggana, M., Fornari, A., Hagar, A., Hall, P. L., Marquardt, G. C., Miller, B. J., et al. (2021) · International Journal of Neonatal Screening · doi:10.3390/ijns7020023 · Cited by 26
“In rare cases, programs also measure thyroid binding globulin (TBG) [35] or free T4 [36], but no program measuring TBG or free T4 for screening purposes was included in this comparative study.”
BackgroundCritical evaluation of the newborn screening for congenital hypothyroidism in the Netherlands
Stroek, K., Heijboer, A. C., Bouva, M. J., van der Ploeg, C. P. B., Heijnen, M. A., Weijman, G., Bosch, A. M., de Jonge, R., Schielen, P. C. J. I., van Trotsenburg, A. S. P., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-1048 · Cited by 29
van Iersel, L., van Santen, H. M., Zandwijken, G. R. J., Zwaveling-Soonawala, N., Hokken-Koelega, A. C. S., & van Trotsenburg, A. S. P. (2018) · Hormone Research in Paediatrics · doi:10.1159/000486033 · Cited by 23
Sugisawa, C., Takamizawa, T., Abe, K., Hasegawa, T., Shiga, K., Sugawara, H., Ohsugi, K., Muroya, K., Asakura, Y., Adachi, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00657 · Cited by 27
Fujiwara, F., Fujikura, K., Okuhara, K., Tsubaki, J., Fukushi, M., Fujita, K., Fujieda, K., & Tajima, T. (2008) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.17.65 · Cited by 22
Naafs, J. C., Heinen, C. A., Zwaveling-Soonawala, N., van der Schoor, S. R. D., van Tellingen, V., Heijboer, A. C., Fliers, E., Boelen, A., & van Trotsenburg, A. S. P. (2020) · Thyroid® · doi:10.1089/thy.2019.0779 · Cited by 21
“At the same time, high false-positive rates have been reported for T4-based neonatal screening programs (39,40).”
Naafs, J. C., Marchal, J. P., Fliers, E., Verkerk, P. H., Luijten, M. A. J., Boelen, A., van Trotsenburg, A. S. P., & Zwaveling-Soonawala, N. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa901 · Cited by 21
Self-citationConnelly, K. J., Pierce, M. J., Hanna, C. E., & LAFRANCHI, S. H. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479367 · Cited by 21
Zwaveling‐Soonawala, N., van Trotsenburg, A. S. P., & Verkerk, P. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01577 · Cited by 23
Self-citationAmes, J., Windham, G. C., Lyall, K., Pearl, M., Kharrazi, M., Yoshida, C. K., de Water, J. V., Ashwood, P., & Croen, L. (2019) · Autism Research · doi:10.1002/aur.2247 · Cited by 19
Epidemiology of Congenital Hypothyroidism
Olivieri, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_6 · Cited by 19
Evolving Central Hypothyroidism in Children with Optic Nerve Hypoplasia
Ma, N., Fink, C., Geffner, M. E., & Borchert, M. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.23.1-2.53 · Cited by 17
A Japanese Family with Central Hypothyroidism Caused by a Novel IGSF1 Mutation
Nishigaki, S., Hamazaki, T., Fujita, K., Morikawa, S., Tajima, T., & Shintaku, H. (2016) · Thyroid · doi:10.1089/thy.2016.0005 · Cited by 18
Mortality in Children With Early-Detected Congenital Central Hypothyroidism
Zwaveling-Soonawala, N., Naafs, J. C., Verkerk, P. H., & van Trotsenburg, A. S. P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00629 · Cited by 15
Self-citationHealth-Related Quality of Life in Patients With Early-Detected Central Congenital Hypothyroidism
Naafs, J. C., Marchal, J. P., Verkerk, P. H., Fliers, E., van Trotsenburg, A. S. P., & Zwaveling‐Soonawala, N. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab209 · Cited by 17
Self-citationStroek, K., Visser, A., van der Ploeg, C. P. B., Zwaveling‐Soonawala, N., Heijboer, A. C., Bosch, A. M., van Trotsenburg, A. S. P., Boelen, A., Hoogendoorn, M., & de Jonge, R. (2023) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2023.03.001 · Cited by 16
Neonatal screening and a new cause of congenital central hypothyroidism
Tajima, T., Nakamura, A., Morikawa, S., & Ishizu, K. (2014) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2014.19.3.117 · Cited by 16
Heterogeneous phenotype in children affected by non-autoimmune hypothyroidism: an update
Vigone, M. C., Frenna, M. D., & Weber, G. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0288-5 · Cited by 16
“The incidence of C–CH has been described worldwide with a variable rate: an incidence of 1:16,000 has been reported in the Netherlands [2], whereas in Japan it is about 1:30,000 and about 1:100,000 in the United States.”
BackgroundJansen, H. I., van Haeringen, M., Bouva, M. J., den Elzen, W. P. J., Bruinstroop, E., van der Ploeg, C. P. B., van Trotsenburg, A. S. P., Zwaveling‐Soonawala, N., Heijboer, A. C., Bosch, A. M., et al. (2023) · European Thyroid Journal · doi:10.1530/etj-23-0141 · Cited by 14
Wassner, A. J., Cohen, L. E., Hechter, E., & Dauber, A. N. (2013) · Hormone Research in Paediatrics · doi:10.1159/000350013 · Cited by 14
Newborn screening for central congenital hypothyroidism: past, present and future
Garrelfs, M. R., Mooij, C. F., Boelen, A., van Trotsenburg, A. S. P., & Zwaveling‐Soonawala, N. (2025) · European Thyroid Journal · doi:10.1530/etj-24-0329 · Cited by 15
“The Dutch screening program for CH performs equally well at detecting primary CH as TSH-based methods (27, 49).”
InfluentialLoeber, J. G., Platis, D., Zetterström, R. H., & Schielen, P. C. J. I. (2021) · médecine/sciences · doi:10.1051/medsci/2021059 · Cited by 14
Self-citationVliet, G. V., & Grosse, S. D. (2021) · médecine/sciences · doi:10.1051/medsci/2021053 · Cited by 13
Wright, S. J., Jones, C., Payne, K., Dharni, N., & Ulph, F. (2015) · Applied Health Economics and Health Policy · doi:10.1007/s40258-015-0177-2 · Cited by 13
van Tijn, D. A., Schroor, E. J., de Waal, H. A. D., de Vijlder, J. J. M., & Vulsma, T. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0689 · Cited by 13
Self-citationDiagnosing and treating anterior pituitary hormone deficiency in pediatric patients
Rey, R. A., Bergadá, I., Ballerini, M. G., Braslavsky, D. G., Chiesa, A. E., Freire, A. V., Grinspon, R. P., Keselman, A. C., & Arcari, A. J. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09868-4 · Cited by 14
“Congenital isolated TSH deficiency accounts for 25% of the cases of central hypothyroidism [ 45 , 46 ].”
Stroek, K., Heijboer, A. C., van Veen, M., Bosch, A. M., van der Ploeg, C. P. B., Zwaveling‐Soonawala, N., de Jonge, R., van Trotsenburg, A. S. P., & Boelen, A. (2021) · European Thyroid Journal · doi:10.1159/000513516 · Cited by 14
Cost-Effective Analysis of the Congenital Hypothyroidism Screening Program in Sri Lanka
Karunarathna, N., & Hettiarachchi, M. (2021) · Value in Health Regional Issues · doi:10.1016/j.vhri.2021.01.001 · Cited by 14
Congenital isolated central hypothyroidism: Novel mutations and their functional implications
Boelen, A., van Trotsenburg, A. S. P., & Fliers, E. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-820107-7.00010-0 · Cited by 13
van Tijn, D. A., de Vijlder, J. J. M., & Vulsma, T. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0492 · Cited by 11
Self-citationCheetham, T. D., & Wood, C. L. (2024) · Clinical Endocrinology · doi:10.1111/cen.15110 · Cited by 11
“20,41 Most babies (two thirds to three quarters) have additional pituitary hormone deficiencies.”
Neonatal Screening for Congenital Hypothyroidism
Torresani, T. (2014) · Endocrine development · doi:10.1159/000363154 · Cited by 10
Thyroid disease in newborns, infants, and children
van Trotsenburg, A. S. P., & Vulsma, T. (2011) · doi:10.1093/med/9780199235292.003.3273 · Cited by 10
Self-citationRivero‐Arias, O., Png, M. E., White, A. L., Yang, M., Phillips, T., Hinton, L., Boardman, F., McNiven, A., Fisher, J., Thilaganathan, B., et al. (2024) · Health Technology Assessment · doi:10.3310/pytk6591 · Cited by 11
Congenital Hypopituitarism in Neonates
Cherella, C. E., & Cohen, L. E. (2018) · NeoReviews · doi:10.1542/neo.19-12-e742 · Cited by 9
GENETIC DEFECTS IN THYROID HORMONE SUPPLY
Nettore, I. C., Fenzi, G., & Macchia, P. E. (2014) · Cited by 9
van Trotsenburg, A. S. P., Stoupa, A., Léger, J., Rohrer, T. R., Peters, C. J., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.3.8 · Cited by 9
Measuring free thyroxine levels in neonatal heel-prick samples
Boelen, A., van Veen, M., Verkerk, P. H., Gam, D., Loeber, G., Elvers, B., & Endert, E. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.04.004 · Cited by 7
Self-citationVerkerk, P. H., van Trotsenburg, A. S. P., Hoorweg-Nijman, J. J. G., Oostdijk, W., van Tijn, D. A., Kempers, M. J. E., van den Akker, E. L. T., Loeber, J. G., Elvers, L. H., & Vulsma, T. (2014) · Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank · Cited by 9
Self-citationPatyra, K., Makkonen, K., Haanpää, M. K., Karppinen, S., Viikari, L. A., Toppari, J., Reeve, M. P., & Kero, J. T. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.658137 · Cited by 7
“(15), which showed a relatively high (1 in 16 404) occurrence of CeH.”
BackgroundDetermining Reference Ranges for Total T4 in Dried Blood Samples for Newborn Screening
Hijman, A.-I., Konrad, D., & Fingerhut, R. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6010017 · Cited by 8
“They also argue that the costs of adding TBG to a T4 with a reflectory TSH method are acceptable, especially when one considers the costs of long-term morbidity as a consequence of late detection of the disease [34].”
BackgroundBrown, R. S. (2009) · Wiley eBooks · doi:10.1002/9781444316728.ch12 · Cited by 7
Hypothalamic and Pituitary Disorders Affecting the Fetus and Neonate
Cerbone, M., Katugampola, H., & Dattani, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00042-8 · Cited by 5
Hengeveld, R. C. C., Albersen, M., Hadders, M. A., Hellinga, I., Bikker, H., Heijboer, A. C., van Trotsenburg, A. S. P., Hillebrand, J. J., Boelen, A., & Zwaveling‐Soonawala, N. (2021) · Hormone Research in Paediatrics · doi:10.1159/000516691 · Cited by 3
Shibata, N., Numakura, C., Hamajima, T., Miyako, K., Fujiwara, I., Mori, J., Saitoh, A., & Nagasaki, K. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej23-0391 · Cited by 3
Is It Time to Expand Newborn Screening for Congenital Hypothyroidism to Other Rare Thyroid Diseases?
Olivieri, A., Vigone, M. C., Salerno, M., & Persani, L. (2025) · International Journal of Neonatal Screening · doi:10.3390/ijns11030065 · Cited by 4
“In addition, the neonatal diagnosis of central hypothyroidism is also effective in making an earlier diagnosis and treatment of multiple pituitary hormone deficiencies, commonly associated with central CH, thus preventing life-threatening conditions [32,33].”
Central congenital hypothyroidism caused by maternal thyrotoxicosis
Peeters, D., van Gijlswijk, S., Leunissen, R. W. J., & van der Kaay, D. C. M. (2018) · BMJ Case Reports · doi:10.1136/bcr-2017-222620 · Cited by 3
Bernal, S. Y., & Meager, M. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-14895-9_25 · Cited by 2
Laboratory Aspects in Neonatal Screening of Congenital Hypothyroidism
Corbetta, C., & Alberti, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-19213-0_5 · Cited by 1
“000 live borns [ 20 ].”
Gerrits, P. (2006) · Yearbook of Neonatal and Perinatal Medicine · doi:10.1016/s8756-5005(08)70340-8 · Cited by 1
Mutations in IRS4 are associated with central hypothyroidism
Heinen, C. A., de Vries, E. M., Alders, M. M., Bikker, H., Zwaveling‐Soonawala, N., van den Akker, E., Bakker, E., Hoorweg-Nijman, G., Roelfsema, F., Hennekam, R. C. M., et al. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.3.10 · Cited by 1
Congenital Hypothyroidism: Screening, Early Management, and Outcome
Cheetham, T. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65359-x · Cited by 1
Neugeborenenscreening auf Endokrinopathien
Zabransky, S. (2009) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-009-2043-5 · Cited by 2
Genetics, clinical management and natural history of congenital hypothyroidism
Fuqua, J. S. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.2.265
Newborn Screening Results in Children with Central Hypothyroidism
Stockman, J. A. (2012) · Yearbook of Pediatrics · doi:10.1016/j.yped.2010.12.092
Tonelli, F., Cotti, S., Leoni, L., Besio, R., Gioia, R., Marchese, L., Giorgetti, S., Villani, S., Gistelinck, C., Wagener, R., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.5.11
van Trotsenburg, A. S. P., & Zwaveling‐Soonawala, N. (2022) · doi:10.1093/med/9780198870197.003.0174
Travert, G. (2007) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(07)72378-5
Congenital hypothyroidism: Screening, early management and outcome
Cheetham, T. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00241-7
Metadata
- Authors
- Lanting, C. I., van Tijn, D. A., Loeber, J. G., Vulsma, T., de Vijlder, J. J. M., & Verkerk, P. H.
- Affiliations
- Netherlands Organisation for Applied Scientific Research (NL)
- Department of Pediatric Endocrinology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Netherlands
- National Institute for Public Health and the Environment (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2005-07-01
- Volume
- 116
- Issue
- 1
- Pages
- 168-173
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2109362965
- Cited by
- 97
- References
- 16
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 13 · 2020: 6 · 2019: 5 · 2018: 10 · 2017: 5 · 2016: 2 · 2015: 5 · 2014: 9 · 2013: 5 · 2012: 3
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- TNO Repository (submittedVersion)
- Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
- Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- congenital hypothyroidism, newborn screening, thyroxine-binding globulin, thyroxine, thyroid-stimulating hormone, central hypothyroidism, screening method, false positive rate, cost-effectiveness, prevalence, referral criteria
- MeSH terms
- Cost-Benefit Analysis, Costs and Cost Analysis, Congenital Hypothyroidism, False Positive Reactions, Humans, Infant, Newborn, Netherlands, Predictive Value of Tests, Sensitivity and Specificity, Thyrotropin, Thyroxine, Thyroxine-Binding Proteins, Neonatal Screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.